key: cord-0884456-5ynqqrp2
authors: Zhao, Yan; Liu, Shuo; Shi, Zhishang; Zhu, Hangqi; Li, Mingchun; Yu, Qilin
title: Pathogen infection-responsive nanoplatform targeting macrophage endoplasmic reticulum for treating life-threatening systemic infection
date: 2022-04-01
journal: Nano Res
DOI: 10.1007/s12274-022-4211-z
sha: 798c1798691873db420ea8f2db0e5735e56bb9d0
doc_id: 884456
cord_uid: 5ynqqrp2

Systemic infections caused by life-threatening pathogens represent one of the main factors leading to clinical death. In this study, we developed a pathogen infection-responsive and macrophage endoplasmic reticulum-targeting nanoplatform to alleviate systemic infections. The nanoplatform is composed of large-pore mesoporous silica nanoparticles (MSNs) grafted by an endoplasmic reticulum-targeting peptide, and a pathogen infection-responsive cap containing the reactive oxygen species-cleavable boronobenzyl acid linker and bovine serum albumin. The capped MSNs exhibited the capacity to high-efficiently load the antimicrobial peptide melittin, and to rapidly release the cargo triggered by H(2)O(2) or the pathogen-macrophage interaction system, but had no obvious toxicity to macrophages. During the interaction with pathogenic Candida albicans cells and macrophages, the melittin-loading nanoplatform MSNE+MEL+TPB strongly inhibited pathogen growth, survived macrophages, and suppressed endoplasmic reticulum stress together with pro-inflammatory cytokine secretion. In a systemic infection model, the nanoplatform efficiently prevented kidney dysfunction, alleviated inflammatory symptoms, and protected the mice from death. This study developed a macrophage organelle-targeting nanoplatform for treatment of life-threatening systemic infections. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material (N(2) adsorption curves of the initial synthesized MSNs, FT-IR spectra of MSN, and MSNE, MEL release from the FITC-MEL-loading MSNE + TPB induced by different concentration of H(2)O(2), viability of NIH3T3 cells, and DC2.4 cells after treatment of free MEL or the used nanoparticles, effect of MEL on C. albicans growth and macrophage death during the interaction between C. albicans and macrophages, effect of MEL and the nanoparticles on S. aureus growth and macrophage death during the interaction between S. aureus and macrophages, quantification of GRP78 (a) and activated Caspase-3, flow cytometry analysis of kidney non-macrophages with the Alexa Fluor 594 signal, survival curve of the infected mice treated by MEL or MSNE + MEL, kidney burden, blood urea levels and serum TNF-α levels in the infected mice) is available in the online version of this article at 10.1007/s12274-022-4211-z.

Pathogenic infections are always great threats to our human health, frequently leading to worldwide severe pandemics [1] [2] [3] . Especially, abundant life-threatening pathogens, e.g., SARS-CoV-2, Candida albicans, and Staphylococcus aureus, frequently cause severe systemic infections and sepsis when the pathogens enter into the blood and lead to dysregulation of immune response [4] [5] [6] . These dangerous infections may cause multiple organ failures and represent the main cause of infection-related death [7, 8] . One significant consequence of systemic infections is induction of macrophage/neutrophil accumulation and generation of dangerous microthrombi caused by infection-induced inflammatory storms, which is indicated by acute increase in proinflammatory cytokines, e.g., tumor necrosis factor α (TNF-α), interleukin 1 (IL-1), and interleukin 2 (IL-2) [9, 10] . While use of antibiotics is the general way to treat infectious diseases, inhibition of inflammatory storms may be another feasible strategy to protect the body from systemic infection-related death [11, 12] . However, up to now, there are few successful attempts to simultaneously inhibit pathogen growth and suppress inflammatory reactions for efficient treatment of dangerous infections.

Macrophage is one of the most important immune cells fighting against pathogens [13, 14] . During interaction with the pathogens, macrophages commonly phagocytize the pathogens and quickly activate reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidases for generation of reactive oxygen species (ROS) to kill the later [15, 16] . Moreover, binding of macrophage receptors (e.g., Toll-like receptors) to pathogenic cells may activate transcriptional cascades, leading to rapid production of pro-inflammatory cytokines derived from the endoplasmic reticulum (ER), together with ER stress for further enhancement of cytokine production [17, 18] . It is anticipated that ROS/pathogen infection-responsive and macrophage ER-targeting systems may be explored to alleviate ER stress and suppress proinflammatory cytokine production, facilitating attenuation of immune response dysregulation during infection progression. Mesoporous silica nanoparticles (MSNs) are well-known biocompatible nanocarriers used for targeted drug delivery [19] [20] [21] . Dependent on specific gates on the pores, MSNs may load high-level drug cargos, and rapidly sense corresponding stimuli, leading to release of the cargos at aimed organs and tissues [22] [23] [24] [25] . Abundant smart MSN-based nanoplatforms have been developed to respond different physical and chemical stimuli, such as light, magnetic field, heat, pH, and redox agents [26] [27] [28] . For example, a series of ROS-responsive molecules, such as cancer cells, and NIH3T3 fibroblasts were purchased from the Cell Resource Center, China Academy of Medical Science. Mouse neutrophils were isolated from mouse bone marrow by the neutrophil isolation kits (Solarbio, China).

The large-pore MSNs were synthesized by Wang's method with modification [37] . Briefly, 760 mg CTAB, 1.134 g FC2, and 136 mg TEA were dissolved in 50 mL distilled water by 10 min of sonication (500 W, AS20500A, AutoScience, China). The solution was magnetically stirred at 80 °C for 1 h. After addition of 4 mL TEOS, the solution was further stirred for 18 min. The nanoparticles were harvested by centrifugation at 12,000 rpm for 15 min, washed three times by ethanol, and refluxed twice in 100 mL ethanol containing 2 g ammonium nitrate at 80 °C for 1 h. The nanoparticles were re-suspended in 50 mL ethanol containing 2 mL APTES and refluxed at 80 °C for 1 h. The nanoparticles were further harvested by centrifugation at 12,000 rpm for 15 min and washed twice by 100 mL ethanol each time, obtaining the initial large-pore MSN exposing amino groups on the surface.

To graft the large-pore MSNs with ERP, 50 mg of the large-pore MSNs exposing amino groups were suspended in 100 mL of MES buffer (50 mM, pH = 6.0). 10 mg EDC, 11 mg NHSS, and 2 mg ERP were then added into the solution. The mixture was stirred at 4 °C for 24 h. The nanoparticles were harvested by centrifugation at 12,000 rpm for 15 min and washed three times by phosphate buffer saline (PBS), obtaining MSNE. Amino groups on MSN and MSNE were quantified by the SPDP method [28] . The synthesized MSN and MSNE were lyophilized for 24 h by a vacuum freezing drier (Scientz-10N, Xinzhi, China) and weighed for further use.

TSPBA was synthesized by Gu's method [34] . Initially, 1 g 4-(bromomethyl) phenylboronic acid and 0.2 g N,N,N′,N′tetramethyl-1,3-propanediamine were dissolved in 40 mL dimethyl formamide (DMF). The solution was magnetically stirred at 60 °C for 24 h. The reaction solution was then added into 100 mL tetrahydrofuran (THF) and centrifuged at 12,000 rpm for 10 min. The pellets were washed three times by THF and dried by a vacuum desiccator, obtaining TSPBA.

Two methods were used to prepare TPB-capped nanoparticles. In Method 1, 20 mg MSN (containing 2.2 μmol amino groups) or 20 mg MSNE (containing 2.9 μmol amino groups) were suspended in 20 mL PBS (pH = 7.4). Under magnetically stirring, 2 mL TSPBA solution (1 mg/mL, containing 3.6 μmol TSPBA), were slowly added into the solution. The molar contents of TSPBA were higher than the molar contents of amino groups on the nanoparticles to avoid the nanoparticle amino group-TSPBAnanoparticle amino group crosslinking, and therefore to keep one free phenylboronic acid group in each TSPBA molecule for further BSA binding. 5 mL BSA (1 mg/mL, containing 0.072 μmol BSA with 4.4 μmol amino groups and 1.9 μmol guanidyl groups to supply sufficient phenylboronic acid-binding groups) were then added into the mixture. The introduced BSA was used as a macromolecular cap to avoid release of cargos under no stimuli after the cargos were pre-loaded into MSN or MSNE as described in Section 2.7. The mixture was stirred for 30 min at room temperature and centrifuged at 12,000 rpm for 15 min. The pellets were washed twice by PBS, obtaining TPB-capped MSN and MSNE. The unloaded BSA in the supernatants and washing buffer were quantified by the Coomassie brilliant blue agents (Dingguo, China), and the content of loaded BSA was calculated by the initial contents of BSA minus the unloaded BSA. The BSA-loading capacity of the nanoparticles was calculated by the contents of loaded BSA divided by the contents of the nanoparticles × 100%.

In Method 2, 2 mL TSPBA solution (1 mg/mL) and 5 mL BSA (1 mg/mL) were firstly mixed by magnetically stirring for 30 min. The solution was then added into 20 mL PBS (pH = 7.4) containing 20 mg MSN or MSNE. The mixture was further stirred at room temperature for 30 min. The nanoparticles were harvested and washed. The BSA-loading capacity of the nanoparticles was measured as described above.

The morphology of MSN, MSNE, and TPB-capped particles was characterized by transmission electron microscopy (TEM) (Tecnai G2 F-20, FEI). Energy dispersive spectroscopy (EDS) mapping of MSNE+TPB was performed by TEM (JEM 2100F, JEOL, Japan). Size distribution and zeta potential of the nanoparticles in distilled water were analyzed by a zeta-potential analyzer (ZetaPLAS, Brookhaven, USA). The functional groups on the nanoparticles were detected by a Fourier transform infrared (FT-IR) spectrometer (System 2000, PerkinElmer, USA).

To measure MEL-loading capacity of MSN, MSNE, MSN+TPB, and MSNE+TPB, 500 μL nanoparticles (prepared in PBS, 5 mg/mL) were mixed with 500 μL FITC-MEL solution (prepared in PBS, 5 mg/mL). After shaken for 1 h, 50 μL TSPBA (5 mg/mL) and 125 μL BSA (5 mg/mL) were added for the groups of MSN+TPB, and MSNE+TPB. For the groups of MSN and MSNE, 175 μL PBS rather than TSPBA and BSA were added. The mixtures were further shaken for 2 h, centrifuged at 12,000 rpm for 15 min and washed twice by PBS, obtaining MEL-loading nanoparticles. The contents of FITC-MEL in the supernatants and washing solution were detected by a fluorescent microplate reader (PerkinElmer, USA). The MEL-loading capacity (%) was calculated by (the FITC-MEL content of the initial solution − the content in the supernatant − the contents in the washing solution)/the content of nanoparticles × 100%.

MEL-releasing capacity of the nanoparticles were detected by using H 2 O 2 as the stimulus. Briefly, the FITC-MEL-loading nanoparticles, i.e., MSN+MEL, MSNE+MEL, MSN+MEL+TPB, and MSNE+MEL+TPB were suspended in PBS buffer (200 mg/L). After incubation at room temperature for 30 min, 10 mM H 2 O 2 was added into the suspensions. At the indicated time points, the suspensions were sampled and centrifuged at 12,000 rpm for 15 min to remove nanoparticles. FITC-MEL levels in the supernatants were measured by fluorescence microplate reader, and the percent of MEL release from the nanoparticles were calculated by the FITC-MEL content in the supernatant divided by that in the nanoparticles × 100%.

To evaluate the toxicity of free MEL, free nanoparticles, or MELloaded nanoparticles to macrophages, the RAW264.7 cells were cultured in DMEM medium containing 10% fetal bovine serum for 24 h. Free MEL, MSN+MEL+TPB, MSNE+TPB, or MSNE+MEL+TPB at different concentrations were added into the cell cultures. The cells were further cultured for another 24 h. Cell viability was measured by using CCK-8 assay kits (Solarbio, China).

The macrophages were incubated with Rho-MSNE+FITC-MEL+TPB (100 mg/L of Rho-MSNE) for 24 h, followed by infection by 5×10 5 C. albicans (Cal) or S. aureus (Sau) cells/1×10 5 macrophages. After 12 h of infection, the cells were washed twice by PBS, and then observed by confocal microscopy (A1+, NIKON, Japan).

To investigate ER-targeting capacity of the nanoparticles, macrophages were incubated for 24 h with 100 mg/L MSN+MEL+TPB, MSNE+TPB, or MSNE+MEL+TPB, in which MSNs were tagged by FITC. The cells were then washed twice by PBS, and stained by Hoechst 33342 (5 mg/L) and ER-Tracker Red (1 μM) for 30 min. The stained cells were observed by confocal microscopy.

To observe nanoparticle uptake by different kinds of cells, the FITC-tagged MSNE+MEL+TPB (100 mg/L) were added into the corresponding cultures. The cells were further cultured for 24 h, and then stained by Hoechst 33342 and Lyso-Tracker Red for confocal observation. The FITC fluorescence intensity of treated cells were also examined by flow cytometry (FACSCalibur, BD Biosciences).

The effect of the nanoparticles on pathogen-macrophage interaction was evaluated by scanning electron microscopy (SEM) observation, confocal microscopy, fungal colony-forming unit (CFU) assays, ROS assays, Western blotting, and TNF-α assays. The macrophages were infected by 5 × 10 5 C. albicans cells/(1 × 10 5 macrophages), followed by addition of 100 mg/L nanoparticles. The cells were then incubated 12 h for further observation and biochemical analysis.

For SEM observation, the macrophages were fixed by 3% formaldehyde for 2 h, dehydrated by ethanol, dried by a vacuum desiccator, and observed by SEM.

To evaluate macrophage death, the treated cells were stained by propidium iodide (PI) (5 mg/L) and Hoechst 33342 (5 mg/L) for 20 min, followed by confocal microscopy. The percent of dead cells were calculated by the number of PI-positive cells divided by that of Hoechst 33342-stained cells × 100%.

To detect the number of fungal cells, the wells containing the pathogen and the macrophages were washed by distilled water, and the washing solution was diluted by PBS for CFU assays in YPD plates.

For ROS measurement, the treated cells were stained by DCFH-DA (10 mg/L) for 30 min and washed twice by PBS. Fluorescence intensity of the cells was then measured by a fluorescence microplate reader (Enspire, PerkinElmer, USA) with excitation wavelength at 488 nm and with the emission wavelength at 520 nm.

To detect GRP78 and activated caspase-3 levels in the macrophages, the total proteins in the treated macrophages were extracted by using RIPA buffer and separated by SDS-PAGE. GRP78, activated caspase-3, and tubulin were detected by anti-GRP78 antibody, activated caspase-3 antibody, and anti-tubulin antibody, respectively.

To evaluate TNF-α levels secreted by the macrophages, supernatants of the cell cultures were sampled after 12 h of nanoparticle treatment. TNF-α levels in the supernatants were detected by using mouse TNF-α assay kits (Jinbing Sanjiang, China).

All animal experiments were approved by the Animal Care and Use Committee at Nankai University. To investigate the in vivo antimicrobial effect of the nanoparticles, female 5-week-old ICR mice (n = 10, Huafukang, China) were intravenously infected at tail veils by 5 × 10 6 C. albicans SC5314 cells per mouse (Day 0), followed by intravenous injection of the nanoparticles (100 mg/kg) or MEL (20 mg/kg, equal to the dose in the nanoparticles) each day. The Cal group received fungal infection but no agent treatment. The Sham group received PBS infection and no agent treatment. The survival rate and body weights were recorded from Day 0. On Day 3, three mice per group were sacrificed to collect the kidneys. The kidneys were homogenized in saline, and the number of fungal cells in the suspensions was detected by CFU assays in YPD plates. The kidneys were also fixed by 4% formaldehyde, embedded by paraffin, and stained by hematoxylin&eosin (H&E) for histopathological observation. Blood serum in each group was sampled. Serum urea and creatinine were detected by using serum urea assay kits (Solarbio, China) and creatinine assay kits (Nanjing Jiancheng, China), respectively. Serum inflammatory cytokines, including TNF-α, IL-1β, and IL-6, were analyzed by mouse TNF-α, IL-1β, and IL-6 assay kits (Abcam, USA), respectively.

To evaluate kidney targeting of MSNs, the fungus-infected mice were injected by MSN+MEL+TPB, MSNE+TPB, or MSNE+MEL+TPB (100 mg/kg) tagged by Cy5 for mouse body imaging, Alexa Fluor 594 for flow cytometry, or FITC for immunofluorescence staining. After 12 h of injection, the mouse kidneys and other organs were sampled for examination by an animal imaging system (IVIS Lumina II, Xenogen, USA). To analyze kidney macrophage targeting of the MSNs, the infected mice were injected by Alexa Fluor 594-tagged MSN+MEL+TPB, MSNE+TPB or MSNE+MEL+TPB (100 mg/kg). After 12 h of injection, the mouse kidneys were sampled and homogenized, obtaining kidney cell suspensions. The cell suspensions were further stained by FITC-tagged anti-mouse CD163 antibody (indicating macrophages), and examined by flow cytometry. The Alexa Fluor 594-positive and CD163-positive cells indicated kidney macrophages containing the MSNs. For immunofluorescence staining of the kidney tissues, the kidneys were sampled from sacrificed mice, fixed and cut to obtain the ultrathin pieces. The pieces were then stained by rhodamine Btagged anti-CD163 antibody and DAPI for fluorescent microscopy.

Each experiment was performed with three replicates, and the values were shown with means ± SD. Differences between groups were compared by a one-way analysis of variance (ANOVA) test (P < 0.05). All statistical tests were performed using the SPSS software package (Version 20, IBM). Statistical analysis of the survival curves was performed by using the Kaplan-Meier survival model.

To construct a peptide-delivering and ROS-responsive nanoplatform, large-pore mesoporous silica nanoparticles (entitled MSN) were firstly synthesized by using TEOS, CTAB, FC2, and APTES [37] . TEM observation and Brunauer-Emmett-Teller (BET) analysis showed that the obtained MSNs had the diameters of 200-250 nm, with radical pores at the average pore size of 14.71 nm ( Fig. 1(a) and Fig. S1 in the Electronic Supplementary Material (ESM)). The initial MSNs were then covalently conjugated with the ERP (MKWVTFISLLFLFSSAYS) by the EDC/NHSS reaction [32] , obtaining MSNE. The MSNE particles had similar morphology and sizes to the initial MSNs ( Fig. 1(a) ).

Amino group quantified by the SPDP method revealed that MSNE had a higher molar content of amino groups than MSN (145 μmol/g vs. 110 μmol/g, Fig. S2 in the ESM), which was attributed to the introduction of two amino groups with one ERP molecule. FT-IR spectra showed that MSNE had obvious adsorption peaks of the -CO-NH-group as compared with MSN ( Fig. S3 in the ESM), confirming successful covalent modification of ERP on MSN in MSNE.

Owing to the existence of amino groups on the surface of MSN and MSNE, when TSPBA was firstly added into the nanoparticle suspension (Method 1), both MSN and MSNE could adsorb TSPBA by the N-B coordination between the amino group of the nanoparticles and one phenylboronic acid group of TSPBA, and TSPBA could further bind BSA to form the TPB cap by N-B coordination and cation-π interaction using the other free phenylboronic acid group (Fig. S4 in the ESM) [33] [34] [35] [36] . TEM images showed that the TPB-capped MSN and MSNE (i.e., MSN+TPB and MSNE+TPB) had obvious capping layers adhering the MSN surfaces ( Fig. 1(a) ). EDS mapping analysis further revealed the presence of Si, O, B, and N with uniform distribution in MSNE+TPB particles ( Fig. 1(b) ).

Consistently, dynamic light scattering (DLS) and zeta potential analysis showed that the four kinds of particles had slight increased hydration diameters from 240 to 280 nm (Fig. 1(c) ), and the change of zeta potential from +35 mV for the initial MSN to +16 mV for MSNE, and to −18-−15 mV for the TPB-capped particles ( Fig. 1(d) ). The decrease in zeta potential of MSN+TPB and MSNE+TPB may be attributed to the adhered BSA with negative charges under physiological pH. In addition, both MSNE+TSPBA and MSNE+BSA also had negative zeta potentials (−8 and −3 mV, respectively, Fig. S5 in the ESM), confirming the impact of TSPBA and BSA on the charges of MSNE+TPB. Interestingly, Method 1 with TSPBA adsorption onto nanoparticles followed by BSA binding had a higher BSA-loading capacity than Method 2 with TSPBA-BSA mixing followed by nanoparticle adsorption (8.2%-9.0% vs. 4.6%-5.1%, Fig. S6 in the ESM). The lowered loading capacity of Method 2 may be attributed to the interaction of the two phenylboronic acid groups and the amino group or guanidyl groups in BSA, which caused a lack of free phenylboronic acid group for further interaction with the amino groups of nanoparticles. Method 1 was therefore used for further experiments.

The peptide-loading capacity of the four kinds of particles were further evaluated by using FITC-conjugated MEL (GIGAVLKVLTTGLPALISWIKRKRQQ), a model antimicrobial cationic peptide discovered in bee venom [28] . This antimicrobial peptide was used because it has a wide-spectrum antimicrobial spectrum to pathogenic bacteria, fungi, and viruses, and especially inhibits clinical drug-resistant pathogens to overcome severe antibiotic resistance in clinic [38] . While the initial MSN loaded MEL only at a low level (~ 10%), the MSNE and MSN+TPB particles loaded high levels of MEL to 18%-20%. More strikingly, the MSNE+TPB particles loaded the highest level of 28% ( Fig. 1(e) ). These results revealed that covalent modification of ERP and capping with TPB strongly increased peptide-loading capacity of the particles. The increased loading capacity of the MSNE+TPB may be attributed to the introduction of the peptide ERP that rendered the nanoparticles more efficiently binding peptide cargos by electrostatic, π-π and hydrogen bond interactions, and also to the presence of TPB gates that prevented the release of MEL from the pores under no stimuli. Moreover, the MEL-loading capacity (28%) of MSNE+TPB is higher than the loading capacity (13.4%) of MSNs with a pore size at 7-10 nm [28] , indicating that MSNE+TPB is a better candidate for delivery of the antimicrobial peptide in terms of the loading capacity.

The existence of TSPBA may render the TPB-capped MSNs responsiveness to ROS, which leads to oxidation and hydrolyzation of TSPBA for MSN decapping and consequent cargo release (Fig. 2(a) ). To verify this, the MEL-loading particles were treated by H 2 O 2 , a common ROS produced by macrophages suffering from pathogen infection [13] [14] [15] [16] . Before H 2 O 2 treatment at a concentration of 10 mM, while the uncapped MSN and MSNE slowly released MEL, the TPB-capped particles released no MEL in 30 min in PBS buffer ( Fig. 2(b) ), indicating high stability of the capped particles under no stimulus. However, H 2 O 2 addition led to remarkable release of MEL from the TPB-capped MSNs, with the percent of MEL release reaching to 40% at 30 min of H 2 O 2 treatment, and to ~ 60% at 120 min ( Fig. 2(b) ). In contrast, H 2 O 2 had no obvious impact on MEL release (< 10%) from the uncapped particles even at 120 min ( Fig. 2(b) ). The high percent of MEL release from MSNE+MEL+TPB within 120 min may be attributed to the rapid release of MEL from the large pores (~ 14.71 nm, Fig. S1 in the ESM) of MSNE triggered by H 2 O 2induced hydrolysis of TSPBA. Consistently, zeta potential analysis showed that H 2 O 2 addition did not change zeta potential of the uncapped particles, but reversed zeta potential of the capped particles from −18-−16 to > +20 mV (Fig. 2(c) ). TEM observation further confirmed the removal of the TPB layer from the nanoparticle surface by H 2 O 2 treatment (Fig. 2(d) ). Moreover, MEL releasing of the MEL-loading MSNE+TPB increased from 35% to 65% with the increase of H 2 O 2 from 1 to 50 mM (Fig. S7 in the ESM). These results showed that ROS triggered oxidation of TSPBA and consequent gate opening of the TPB-capped particles for MEL release.

The responsiveness of the TPB-capped particles to pathogen infection was further evaluated in mouse RAW264.7 macrophages with infection or not by two clinical pathogens, i.e., the fungal pathogen C. albicans and the bacterial pathogen S. aureus. In the Control group without pathogen infection, after co-incubation of the FITC-MEL-loaded and rhodamine B (Rho)-tagged nanoparticles (Rho-MSNE+FITC-MEL+TPB) for 12 h, the nanoparticles were strongly internalized into macrophages, with the fluorescence of Rho-MSNE and FITC-MEL co-localized to a high degree in the cells (indicated by the white arrows, Fig. 2(e) ). Statistical analysis of Pearson's correlation coefficient (PCC), which reflects the co-localization efficiency [39] , further showed a high PCC value of 0.8 in the Control group. However, after infection by C. albicans or S. aureus, most of FITC-MEL were not co-localized with Rho-MSNE (PCC value < 0.36, Figs. 2(e) and 2(f)), indicating remarkable release of the cargo from the particles triggered by ROS. Therefore, the TPB-capped MSNs could sensitively respond to both ROS and macrophages infected by pathogens.

Macrophages are one of the main immune cells phagocytosing pathogens and producing pro-inflammatory factors for inflammation activation [13] [14] [15] [16] . It is expected that the TPBcapped MSNE nanoparticles target macrophages for further macrophage-induced drug release and inflammation inhibition. To confirm this, the RAW264.7 macrophages, together with three kinds of non-macrophages, i.e., the mouse-isolated neutrophils, the DC2.4 dendritic cells, and the human MCF-7 breast cancer cells, were used for evaluating the targeting capacity of the nanoparticles. Confocal microscopy and flow cytometry showed that the macrophages treated by the FITC-tagged MSNE nanoparticles containing MEL and TPB (FITC-MEL+MEL+TPB) had strong FITC fluorescence after 24 h (Fig. 3(a) ), with the peak of FITC intensity remarkably shifting to the range of high intensity ( Fig. 3(b) ). Moreover, FITC fluorescence of the nanoparticles was only partially co-localized with the fluorescence of Lyso-Tracker Red (indicated by the white arrows, Fig. 3(a) ), indicating that partial nanoparticles may escape from the lysosomes. In contrast, after treatment of the nanoparticles, the non-macrophages, including neutrophils, DC2.4 cells, and MCF-7 cells, only exhibited slight FITC signals (Figs. 3(c)-3(h) ). These results indicated that the TPB-capped MSNE nanoparticles specifically targeted the macrophages, rendering strong uptake of the nanoparticles by the macrophages. The high specificity of TPBcapped MSNE may be attributed to recognition of high-expressed BSA-binding receptors on the surface of macrophages [40] .

ERP may facilitate the particles to further target the ER [32, 41, 42] . As expected, confocal observation showed that the MEL-loading and FITC-tagged MSNs (MSN+MEL+TPB) not modified by ERP were internalized into the macrophages but scarcely co-localized with ER-Tracker ( Fig. 4(a) ), with the PCC value of only 0.23 ( Fig. 4(b) ). In contrast, the ERP-modified particles, i.e., MSNE+TPB and MSNE+MEL+TPB, were abundantly co-localized with ER-Tracker (PCC value = 0.65-0.71, Figs. 4(a) and 4(b)). Therefore, covalent modification of ERP to MSNs led to high ER-targeting capacity of the MEL-loading particles. It is interesting that TPB-coating on the surface of MSNE did not impair the ER-targeting capacity (Figs. 4(a) and 4(b) ). This may be attributed to partial decapping of MSNE+MEL+TPB during its interaction with the macrophage plasma membrane and consequent exposure of ERP on the nanoparticle surface.

Cargo loading into MSNs is a useful strategy to enhance biocompatibility of the cargos [43, 44] . Indeed, as revealed by CCK-8 assays, free MEL exhibited high toxicity to macrophages, leading to drastic decrease in cell viability to < 10% at 25 mg/L (Fig. 4(c) ). In contrast, the MEL-loading particles, including MSN+MEL+TPB, MSNE+TPB, and MSNE+MEL+TPB, had no obvious toxicity to the cells, even when the particle concentration reached up to 200 mg/L (containing MEL 50 mg/L, Fig. 4(c) ). Similar results were observed in the NIH3T3 fibroblasts and the DC2.4 dendritic cells (Fig. S8 in the ESM) . Consistently, while free MEL caused remarkable accumulation of intracellular ROS and production of the inflammation-inducing cytokine TNF-α, the MEL-loading, and TPB-capped particles only led to slight ROS accumulation and TNF-α production (Figs. 4(d) and 4(e) ). These results indicated that the TPB-capped particles containing MEL had good biocompatibility for further application.

To evaluate the effect of the TPB-capped MSNE on pathogen infection, a pathogen-macrophage interaction model was used. As revealed by SEM and confocal observation, after co-incubation of the fungal pathogen C. albicans (Cal) with macrophages for 12 h without nanoparticle treatment, the pathogen formed long and dense hypha, and almost no macrophage was observed (Figs. 5(a) and 5(b)), indicating that the fungal pathogen developed hyphal cells and severely damaged the macrophages. Similarly, in the groups of Cal+MSN+MEL+TPB or Cal+MSNE+TPB, the pathogen also formed long hyphal cells and damaged most of macrophages (Figs. 5(a) and 5(b)). In contrast, in the group of Cal+MSNE+MEL+TPB, the growth of pathogen hyphae was thoroughly inhibited, and the macrophages remained intact morphology (Figs. 5(a) and 5(b)). CFU assays and statistical analysis further revealed that MSNE+MEL+TPB led to drastic decrease in fungal CFU from 6.3 × 10 6 to < 10 2 per microliter (Fig. 5(c) ), and in the percent of dead macrophages from 98% to < 10% (Fig. 5(d) ). In contrast, MSN+MEL+TPB or MSN+TPB only partially decreased the number of fungal CFU and dead macrophages (Figs. 5(c) and 5(d)). In addition, free MEL at 50 mg/L almost kill all macrophages but only partially reduced fungal CFU to 2.5 × 10 4 (Fig. S9 in the ESM) , indicating that the strong inhibitory effect of MSNE+MEL+TPB on fungal growth is attributed not only to MEL, but also to the presence of MSNE+TPB. Similarly, MSNE+MEL+TPB exhibited higher inhibitory effect on S. aureus (Fig. S10(a) in the ESM), and survived most macrophages suffering from S. aureus infection (Fig. S10(b) in the ESM).

Pathogen infection frequently induces inflammation by activating cellular response of macrophages, e.g., ER stress, apoptosis activation, production of pro-inflammatory cytokines, and ROS storm [45] [46] [47] . Western blotting was firstly performed to detect the ER stress reporting protein GRP78 and the apoptosis factor activated caspase-3 [48, 49] . After C. albicans infection for 12 h, the levels of both GRP78 and activated caspase-3 were remarkably upregulated as compared with uninfected macrophages (Fig. S11 in the ESM) . Strikingly, while MSN+MEL+TPB and MSNE+TPB had no obvious effect on these two proteins in the C. albicans-infected macrophages, MSNE+MEL+TPB remarkably down-regulated the levels of the two proteins (Fig. 5(e) and Fig. S12 in the ESM). Consistently, MSNE+MEL+TPB strongly reduced TNF-α production and intracellular ROS accumulation, while MSN+MEL+TPB and MSNE+TPB only slightly decrease TNF-α and ROS levels (Figs. 5(f) and 5(g)). These results implied that MSNE+MEL+TPB strongly attenuated pathogen-induced ER stress, apoptosis, production of inflammatory factors, and ROS storm, which may suppress pathogen-induced inflammation.

To confirm the role of MSNE+MEL+TPB in attenuation of systemic infections, a mouse model of life-threatening systemic infection by C. albicans was used, in which the fungal pathogen was intravenously injected into the mice at tail veins. Organ imaging showed that Cy5-tagged MSNE+MEL+TPB, similar to MSN+MEL+TPB and MSNE+TPB, was distributed abundantly in the kidney, and partially in liver and spleen ( Fig. 6(a) ). Moreover, flow cytometry analysis of kidney cells further revealed that 45% of kidney macrophages (FITC-CD163-positive cells) had the fluorescence signal of Alexa Fluor 594-tagged MSNE+MEL+TPB ( Fig. 6(b) ), while less than 5% kidney non-macrophages (FITC-CD163-negative cells) had the Alexa Fluor 594 signal (Fig. S13 in the ESM). In contrast, in the group of MSN+MEL+TPB and MSNE+TPB, only 28%-32% of kidney macrophages had the Alexa Fluor 594 signal ( Fig. 6(b) ). Immunofluorescence staining further showed that most of the FITC-tagged MSN+MEL+TPB nanoparticles were co-localized with the macrophages labeled by rhodamine B-tagged anti-CD163 antibody, while abundant MSN+MEL+TPB and MSNE+TPB failed to be co-localized with the macrophages (Fig. 6(c) ). These results indicated that MSNE+MEL+TPB preferentially accumulated in the kidneys and further targeted the kidney macrophages. Mouse survival rate was then monitored after the infected mice were treated by the nanoparticles. In four days after infection by the fungal cells, all mice were dead in the group receiving no particle treatment (Fig. 7(a) ), confirming that C. albicans led to life- threatening infection. In contrast, mouse survival time was obviously prolonged in the nanoparticle-treated groups. Especially, MSNE+MEL+TPB prolonged the survival time of all mice > 6 days and survived 60% of mice even after 14 days, while MSN+MEL+TPB and MSNE+TPB failed to survive the mice after 8 days (Fig. 7(a) ). Consistently, whereas the Cal group and the groups treated by MSN+MEL+TPB or MSNE+TPB had rapid decrease in body weight after fungal infection, the group treated by MSNE+MEL+TPB showed only a slight weight decrease in the first 4 days, and then a gradual increase in body weight ( Fig. 7(b) ), which may be attributed to attenuation of fungal infection. In addition, all of the mice in the groups MEL alone with the dose equal to that in the nanoparticles died in 2 days (Fig. S11 in the ESM), indicating that the use of the MSNE+MEL+TPB nanoplatform efficiently prevented the toxicity of MEL after intravenous infection. Moreover, all the mice treated by MSNE+MEL also died in 7 days (Fig. S14 in the ESM), suggesting that the presence of TPB is of significance in prevention of the infection-caused mouse death. The critical role of TPB may be associated with its capping activity that enhanced the MELloading capacity, and with the improvement of macrophagetargeting ability. Systemic C. albicans infection is frequently followed by fungal invasion to kidneys, disruption of kidney functions, and sepsis [50] [51] [52] . Indeed, in the Cal group, the mouse kidneys suffered from severe fungal hyphal invasion and inflammation, with obvious tissue damage and high fungal burden, and the mice showed high levels of blood urea and TNF-α levels as compared with the uninfected kidneys (Fig. S15 in the ESM). As revealed by H&E staining and Periodic Acid-Schiff (PAS) staining of kidney tissues, both MSN+MEL+TPB and MSNE+TPB only slightly affected fungal invasion into the kidney tissues. In contrast, MSNE+MEL+TPB prevented the mouse kidneys from fungal invasion, and attenuated inflammation in the kidneys (Figs. 7(c) and 7(d)), with the kidney fungal burden decreased from 10 6 to < 10 3 fungal cells/g kidney (Fig. 7(e) ). Moreover, MSNE+MEL+TPB strongly decreased the levels of serum urea and creatinine on Day 3 ( Fig. 7(f) and Fig. S16(a) in the ESM), together with the levels of the inflammatory cytokines, including TNF-α, IL-1β, and IL-6 ( Fig. 7(g) and Figs. S16(b) and S16(c) in the ESM). Especially, the levels of the cytokines in the MSNE+MEL+TPB group reached to the normal levels of the Sham group without fungal infection (Fig.  S17 in the ESM). In contrast, the other groups had high levels of these inflammatory factors (Figs. 7(f) and 7(g), and Figs. S16 and S17 in the ESM). Together, these results revealed that MSNE+MEL+TPB efficiently attenuated the life-threatening systemic infection, and suppressed kidney damage and infectioncaused inflammation. 

In summary, this study developed a pathogen infection-activated nanoplatform for alleviation of life-threatening systemic infections. This nanoplatform was composed of ERP-grafted MSNs capped by the ROS-responsive TSPBA-linked BSA. Under treatment of H 2 O 2 or the pathogen-infected macrophage, the MEL-loading nanoparticles sensitively opened the TPB gates for quick release of the cargo. During incubation of pathogens with macrophages, the antimicrobial peptide-loading nanoparticles strongly suppressed pathogen growth, and protected the macrophages from apoptosis, pro-inflammatory factor secretion, and ROS accumulation. In the mouse model of life-threatening systemic infection, the nanoparticles efficiently protected the infected mice from death and suppressed pathogen invasion into kidneys. This study develops a novel pathogen infection-responsive gate of mesoporous materials, and provides an intelligent nanoplatform for efficient attenuation of systemic infections caused by lifethreatening pathogens. between S. aureus and macrophages, quantification of GRP78 (a) and activated Caspase-3, flow cytometry analysis of kidney nonmacrophages with the Alexa Fluor 594 signal, survival curve of the infected mice treated by MEL or MSNE + MEL, kidney burden, blood urea levels and serum TNF-α levels in the infected mice) is available in the online version of this article at https://doi.org/10.1007/s12274-022-4211-z.

The pandemic exposes human nature: 10 evolutionary insights

Opportunities and challenges in modeling emerging infectious diseases

Nanomaterial-based strategies in antimicrobial applications: Progress and perspectives

Antifungal drug resistance: Molecular mechanisms in Candida albicans and beyond

Proteomic atlas of organ vasculopathies triggered by Staphylococcus aureus sepsis

SARS-CoV-2 and viral sepsis: Observations and hypotheses

Polydopamine/silver hybrid coatings on soda-lime glass spheres with controllable release ability for inhibiting biofilm formation

TREML4 receptor regulates inflammation and innate immune cell death during polymicrobial sepsis

Sepsis and septic shock

The pathophysiology and treatment of sepsis

Cutting edge: IL-1α and not IL-1β drives IL-1R1-dependent neonatal murine sepsis lethality

Biomaterial-driven immunomodulation: Cell biology-based strategies to mitigate severe inflammation and sepsis

Reactive oxygen species-responsive polymeric nanoparticles for alleviating sepsisinduced acute liver injury in mice

Immunometabolism at the interface between macrophages and pathogens

TNF induces pathogenic programmed macrophage necrosis in tuberculosis through a mitochondrial-lysosomalendoplasmic reticulum circuit

The proinflammatory effects of macrophage-derived NADPH oxidase function in autoimmune diabetes. Free Radic

Insights into the role of endoplasmic reticulum stress in infectious diseases

PGRS domain of Mycobacterium tuberculosis PE_PGRS protein Rv0297 is involved in endoplasmic reticulum stress-mediated apoptosis through Toll-like receptor 4

Silver nanoparticles-decorated and mesoporous silica coated single-walled carbon nanotubes with an enhanced antibacterial activity for killing drug-resistant bacteria

Synthetic amorphous silica nanoparticles: Toxicity, biomedical and environmental implications

Probing the local nanoscale heating mechanism of a magnetic core in mesoporous silica drug-delivery nanoparticles using fluorescence depolarization

Use of ferritin capped mesoporous silica nanoparticles for redox and pH triggered drug release in vitro and in vivo

Supramolecular nanomachines as stimuli-responsive gatekeepers on mesoporous silica nanoparticles for antibiotic and cancer drug delivery

Zwitterionic carbon dotencapsulating pH-responsive mesoporous silica nanoparticles for NIR light-triggered photothermal therapy through pH-controllable release

Smart MSN-drug-delivery system for tumor cell targeting and tumor microenvironment release

Gated mesoporous silica nanocarriers for hypoxia-responsive cargo release

Polydopamine functionalized mesoporous silica as ROS-sensitive drug delivery vehicles for periodontitis treatment by modulating macrophage polarization

Supramolecular assemblies of heterogeneous mesoporous silica nanoparticles to codeliver antimicrobial peptides and antibiotics for synergistic eradication of pathogenic biofilms

Redox-sensitive nanoscale drug delivery systems for cancer treatment

Reactive-oxygen-speciesresponsive drug delivery systems: Promises and challenges

A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem

Targeting specific cell organelles with different-faceted nanocrystals that are selectively recognized by organelle-targeting peptides

Core-shell microneedle gel for self-regulated insulin delivery

A dual-bioresponsive drug-delivery depot for combination of epigenetic modulation and immune checkpoint blockade

In situ forming and H 2 O 2 -releasing hydrogels for treatment of drugresistant bacterial infections

boronic acid-rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing

Kinetically controlled dendritic mesoporous silica nanoparticles: From dahlia-to pomegranate-like structures by micelle filling

Melittin: From honeybees to superbugs

A practical guide to evaluating colocalization in biological microscopy

Adsorbed serum proteins responsible for surface dependent human macrophage behavior

Cell-penetrating peptide-conjugated lipid/polymer hybrid nanovesicles for endoplasmic reticulum-targeting intracellular delivery

The mechanisms by which pardaxin, a natural cationic antimicrobial peptide, targets the endoplasmic reticulum and induces c-FOS

Magnetism, ultrasound, and light-stimulated mesoporous silica nanocarriers for theranostics and beyond

Glucose-and pH-responsive controlled release of cargo from protein-gated carbohydrate-functionalized mesoporous silica nanocontainers

Circulating BiP/Grp78 is a novel prognostic marker for sepsismediated immune cell death

Mechanisms of mortality in early and late sepsis

GADD34 suppresses lipopolysaccharide-induced sepsis and tissue injury through the regulation of macrophage activation

Activation of cell surface GRP78 decreases endoplasmic reticulum stress and neuronal death

Endoplasmic reticulum stress precedes oxidative stress in antibioticinduced cholestasis and cytotoxicity in human hepatocytes. Free Radic

Local antifungal immunity in the kidney in disseminated candidiasis

Phospholipid/protein co-mediated assembly of Cu 2 O nanoparticles for specific inhibition of growth and biofilm formation of pathogenic fungi

Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease

We thank Prof. Jeffry Zink for constructive suggestions to this study. This work was supported by the National Natural Science Foundation of China (Nos. 3217010793 and 31870139), Natural Science Foundation of Tianjin (No. 19JCZDJC33800), and Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project (No. TSBICIP-KJGG-006).